Inventor · disambiguated record
Scott L. Dax
Also filed as: DAX SCOTT · DAX SCOTT L
50 granted patents·30 pending applications·472 citations·filing 1999–2024
98Inventor score
Files withJANSSEN PHARMACEUTICA NV16MEBIAS DISCOVERY INC7COLBURN RAYMOND W6ACADIA PHARM INC5CERSCI THERAPEUTICS INC5
Top patents by PatentIndex Score
80 records- 0195US11161826B2Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agentACADIA PHARM INC·Filed 2020·Granted Nov 2, 2021·3 cites·6 claims
- 0294US6140354AN-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disordersORTHO MCNEIL PHARM INC·Filed 1999·Granted Oct 31, 2000·152 cites·22 claims
- 0392US8685990B2Pyrimidine compounds as delta opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 1, 2014·19 cites·3 claims
- 0492US6380224B1Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disordersORTHO MCNEIL PHARM INC·Filed 2000·Granted Apr 30, 2002·46 cites·9 claims
- 0588US8809327B2Sulfonamides as TRPM8 modulatorsBRANUM SHAWN T·Filed 2012·Granted Aug 19, 2014·13 cites·5 claims
- 0688US8324217B2Cold menthol receptor antagonistsCOLBURN RAYMOND W·Filed 2012·Granted Dec 4, 2012·13 cites·11 claims
- 0788US8153682B2Sulfonamides as TRPM8 modulatorsBRANUM SHAWN T·Filed 2008·Granted Apr 10, 2012·16 cites·37 claims
- 0888US8143259B2Cold menthol receptor antagonistsCOLBURN RAYMOND W·Filed 2009·Granted Mar 27, 2012·13 cites·24 claims
- 0986US8653099B2Cold menthol receptor antagonistsCOLBURN RAYMOND W·Filed 2009·Granted Feb 18, 2014·9 cites·27 claims
- 1086US8415341B2Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitorsCHEVALIER KRISTEN·Filed 2010·Granted Apr 9, 2013·18 cites·18 claims
- 1185US7553850B2Tricyclic-bridged piperidinylidene derivatives as δ-opioid modulatorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Jun 30, 2009·8 cites·24 claims
- 1285US7439239B2Tricyclic δ- opioid modulatorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Oct 21, 2008·8 cites·87 claims
- 1384US7432257B2Piperdinyl-phenoxazine and phenothiazine derivatives as δ-opioid modulatorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Oct 7, 2008·8 cites·6 claims
- 1484US6984647B2Aminotetralin-derived urea modulators of vanilloid VR1 receptorJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jan 10, 2006·15 cites·51 claims
- 1583US7951829B2Benzimidazole modulators of VR1JANSSEN PHARMACEUTICA NV·Filed 2007·Granted May 31, 2011·6 cites·17 claims
- 1683US7678812B2Aminotetralin-derived urea modulators of vanilloid VR1 receptorJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Mar 16, 2010·5 cites·4 claims
- 1782US8846655B24-substituted-2-phenoxy-phenylamine delta opioid receptor modulatorsCOATS STEVEN J·Filed 2010·Granted Sep 30, 2014·7 cites·24 claims
- 1882US6841552B13a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptide Y receptors ligands useful in the treatment of obesity and other disordersORTHO MCNEIL PHARM INC·Filed 2000·Granted Jan 11, 2005·16 cites·17 claims
- 1982US2025282731A1Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using sameMEBIAS DISCOVERY INC·Filed 2024·Application pending·0 cites
- 2081US8569505B2Aminotetralin-derived urea modulators of vanilloid VR1 receptorCODD ELLEN·Filed 2010·Granted Oct 29, 2013·5 cites·52 claims
- 2180US9162992B2Compounds and compositions for treatment of breathing control disorders or diseasesGALLEON PHARMACEUTICALS INC·Filed 2014·Granted Oct 20, 2015·5 cites·33 claims
- 2280US7897781B2Cold menthol receptor-1 antagonistsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Mar 1, 2011·6 cites·39 claims
- 2378US12162837B2Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using sameMEBIAS DISCOVERY INC·Filed 2022·Granted Dec 10, 2024·0 cites·22 claims
- 2478US9102636B2Analgesic compounds, compositions, and uses thereofMANNION JAMES C·Filed 2011·Granted Aug 11, 2015·10 cites·3 claims
- 2577US8394828B2Quinoline-derived amide modulators of vanilloid VR1 receptorCODD ELLEN·Filed 2008·Granted Mar 12, 2013·3 cites·142 claims
- 2677US6987188B23a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disordersDAX SCOTT·Filed 2004·Granted Jan 17, 2006·13 cites·4 claims
- 2775US2022168279A1Methods of treating pain with a thiazoline anti-hyperalgesicACADIA PHARM INC·Filed 2021·Application pending·0 cites
- 2874US7183411B2Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptorJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Feb 27, 2007·7 cites·5 claims
- 2974US6201025B1N-aralkylaminotetralins as ligands for the neuropeptide Y Y5 receptorORTHO MCNEIL PHARM INC·Filed 1999·Granted Mar 13, 2001·35 cites·16 claims
- 3073US9351972B2Compounds as respiratory stimulants for treatment of breathing control disorders or diseasesDAX SCOTT L·Filed 2011·Granted May 31, 2016·5 cites·5 claims
- 3171US2020246316A1Methods of treating post-surgical pain with a thiazoline anti-hyperalgesic agentCERSCI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3270US8895573B2Phenoxy-substituted pyrimidines as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Nov 25, 2014·1 cites·3 claims
- 3370US7589104B2Tricyclic-bridged piperidinyline derivatives as §-opioid modulatorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Sep 15, 2009·1 cites·19 claims
- 3470US2022153731A1Compounds for Pain Treatment, Compositions Comprising Same, and Methods of Using SameACADIA PHARM INC·Filed 2021·Application pending·0 cites
- 3569US11091473B2Compounds for pain treatment, compositions comprising same, and methods of using sameACADIA PHARM INC·Filed 2019·Granted Aug 17, 2021·0 cites·7 claims
- 3669US10844054B2Compounds for pain treatment, compositions comprising same, and methods of using sameCERSCI THERAPEUTICS INC·Filed 2019·Granted Nov 24, 2020·0 cites·23 claims
- 3768US11319290B2Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using sameMEBIAS DISCOVERY INC·Filed 2020·Granted May 3, 2022·0 cites·23 claims
- 3867US2020289474A1Methods of treating pain with a thiazoline anti-hyperalgesicCERSCI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3966US7071195B2Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disordersORTHO MCNEIL PHARM INC·Filed 2002·Granted Jul 4, 2006·2 cites·8 claims
- 4066US2022267285A1Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agentACADIA PHARM INC·Filed 2021·Application pending·0 cites
- 4166US2022315567A1Substituted Ureas and Methods of Making and Using SameMEBIAS DISCOVERY INC·Filed 2021·Application pending·0 cites
- 4265US11198685B2Substituted ureas and methods of making and using sameMEBIAS DISCOVERY INC·Filed 2020·Granted Dec 14, 2021·0 cites·18 claims
- 4365US7317025B2Non-peptidic NPY Y2 receptor inhibitorsJOHNSON & JOHNSON PHARM RES·Filed 2004·Granted Jan 8, 2008·2 cites·10 claims
- 4464US10294228B2Breathing control modulating compounds, and methods of making and using sameNEURAD LTD·Filed 2016·Granted May 21, 2019·1 cites·52 claims
- 4564US2010093709A1Tricyclic delta opioid modulatorsCOATS STEVEN J·Filed 2009·Application pending·0 cites
- 4662US7652005B2Tricyclic δ-opioid modulatorsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Jan 26, 2010·0 cites·81 claims
- 4762US2020246318A1Methods of treating pain with a thiazoline anti-hyperalgesicCERSCI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4861US10836728B2Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using sameMEBIAS DISCOVERY INC·Filed 2018·Granted Nov 17, 2020·0 cites·20 claims
- 4960US9434711B2Sulfonamides as TRPM8 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Sep 6, 2016·0 cites·2 claims
- 5059US10683283B2Substituted ureas and methods of making and using sameMEBIAS DISCOVERY INC·Filed 2017·Granted Jun 16, 2020·0 cites·18 claims
Showing the top 50 of 80 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →